473
Views
13
CrossRef citations to date
0
Altmetric
Letter to the Editor

Acute myeloid leukemia in Jehovah Witnesses

, &
Pages 817-820 | Received 26 Nov 2007, Accepted 10 Jan 2008, Published online: 01 Jul 2009

References

  • Jansen A JG, Caljouw M AA, Hop W CJ, van Rhenen D J, Schipperus M R. Feasibility of a restrictive red-cell transfusion policy for patients with intensive chemotherapy for acute myeloid leukaemia. Transfusion Med 2004; 14: 33–38
  • Brown N M, Matthew B, Ford P A. Treatment of a Jehovah's Witness using a transfusion-free autologous stem cell transplant protocol. Community Oncol 2006; 3: 776–781
  • Agrawal Y P, Freedman M, Szczepiorkowski Z M. Long-term transfusion of polymerized bovine hemoglobin in a Jehovah's Witness following chemotherapy for myeloid leukemia: a case report. Tranfusion 2005; 45: 1735–1738
  • Bareford D, Odeh B, Narayanan S, Wiltshire S. Remission induction in a Jehovah's Witness patient with acute myeloid leukeamia using gemtuzumab ozogamicin. Transfusion Med 2005; 15: 445–448
  • Broccia G. Long-term continuous complete remission of acute myeloid leukemia in a Jehovah's Witness treated without blood support. Haematologica 1994; 79: 180–181
  • Cullis J O, Duncombe A S, Dudley J M, Lumley H S, Apperley J F, Smith A G. Acute leukemia in Jehovah's Witnesses. Br J Haematol 1998; 100: 664–668
  • Dainer P M, Knupp C L, Sartiano G P. Low-dose cytosine arabinoside as an alternative treatment for acute leukemia in Jehovah's Witnesses. Am J Hematol 1992; 40: 2156–2157
  • Dalal S, Boddapati M, Lowery M N, Veillon D M, Glass J, Munker R. Treatment of acute myeloid leukemia in a Jehovah's Witness. Ann Hematol 2006; 85: 407–408
  • Goldberg S L, Chan C SP, Dawkins F W, Mehlman T W, Schechter G P. Should Jehovah's Witnesses be denied intensive chemotherapy for acute leukemia. NEJM 1990; 322: 777–778
  • Hargis J B, Waddell D J, Diehl L, Redmond J. Induction chemotherapy in Jehovah's Witnesses with leukaemia. Lancet 1990; 2: 563–564
  • Kerridge I, Lowe M, Seldon M, Enno A, Deveridge S. Clinical and ethical issues in the treatment of a Jehovah's Witness with acute myeloblastic leukemia. Arch Intern Med 1997; 157: 1753–1757
  • Laszlo D, Agazzi A, Goldhirsch A, Cinieri S, Bertolini F, Rabascio C, et al. Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat. Eur J Haematol 2004; 72: 264–267
  • Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A. Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. Haematologica 2000; 85: 1221–1222
  • Nouisiainen T, Jantunen E, Lahtinen R. Jehovah's Witnesses and acute leukemia. Am J Hem 1993; 43: 158–159
  • Wandt H, Schaefer-Eckart K, Wilhelm M. Two allogeneic hematopoietic stem cell transplantations without the use of blood-product support. Haematologica 2005; 90: 1292–1294

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.